STTK · NASDAQ · Biotechnology

Shattuck Labs (STTK)

Develops DR3-blocking antibodies for inflammatory and immune-mediated diseases.

$6.98
Pre-market+0.07 (+1.01%)
At close$6.91(+0.58%)

Something off on this page? Send us feedback.

Next report
Nov 10, 2026
in 68 days
EPS estimate
−$0.10
Revenue estimate
$37.5K
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.37−$0.27−$0.24−$0.14−$0.12−$0.13−$0.12Pending
Estimate−$0.38−$0.29−$0.25−$0.15−$0.12−$0.14−$0.12−$0.10
Surprise+2.6%+6.9%+4.0%+6.7%0.0%+7.1%+3.3%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$14.5M$1.0MPending
Estimate$799.4K$166.7K$250.0K$37.5K
Surprise+1,712.9%+500.0%

History

DateEstimateReportedSurprise
Nov 2026−$0.10
Aug 2026−$0.12−$0.12+3.3%
May 2026−$0.14−$0.13+7.1%
Mar 2026−$0.12−$0.120.0%
Nov 2025−$0.15−$0.14+6.7%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Oct 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 10, 2026−$0.10$37.5K
Aug 11, 2026−$0.12−$0.12+3.3%+0.6%
May 7, 2026−$0.14−$0.13+7.1%+9.4%
Mar 5, 2026−$0.12−$0.120.0%$250.0K+17.5%
Nov 6, 2025−$0.15−$0.14+6.7%$166.7K$1.0M+500.0%+1.0%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 14, 2025
May 1, 2025
Mar 27, 2025
Nov 14, 2024
Aug 1, 2024
May 2, 2024
Feb 29, 2024
Nov 9, 2023
Aug 10, 2023
May 9, 2023
Feb 23, 2023
Nov 8, 2022
Aug 11, 2022
May 12, 2022
Mar 15, 2022
Nov 9, 2021
Aug 11, 2021
May 10, 2021
Mar 15, 2021
Nov 13, 2020
Oct 13, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019